RecruitingPhase 4NCT05548283
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
Studying Digestive tract malformation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Chris Goss
- Principal Investigator
- Patrick Flume, MDMedical University of South Carolina
- Intervention
- Beta-lactam antibiotic(drug)
- Enrollment
- 730 target
- Eligibility
- 6 years · All sexes
- Timeline
- 2023 – 2026
Study locations (30)
- The Children's Hospital Alabama, University of Alabama at Birmingham, Birmingham, Alabama, United States
- Tucson Cystic Fibrosis Center, Tucson, Arizona, United States
- University of California San Diego, La Jolla, California, United States
- Long Beach Memorial Medical Center, Long Beach, California, United States
- CHOC Children's Hospital, Orange, California, United States
- University of California at Davis Medical Center, Sacramento, California, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- University of Florida, Gainesville, Florida, United States
- Joe DiMaggio Children's Hospital, Hollywood, Florida, United States
- Nemours Children's Clinic, Jacksonville, Florida, United States
- University of Miami, Miami, Florida, United States
- All Children's Hospital, St. Petersburg, Florida, United States
- Emory University, Atlanta, Georgia, United States
- Saint Luke's Cystic Fibrosis Center of Idaho, Boise, Idaho, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
University of Washington · Medical University of South Carolina · Cystic Fibrosis Foundation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05548283 on ClinicalTrials.govOther trials for Digestive tract malformation
Additional recruiting or active studies for the same condition.